Join
Live feed
·
INSIDERFilingvia Quantisnow
Whitehawk Therapeutics Inc. logo

CHIEF EXECUTIVE OFFICER Lennon David James converted options into 16,250 shares and sold $16,879 worth of shares (5,100 units at $3.31), increasing direct ownership by 33% to 44,579 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WHWK (Whitehawk Therapeutics Inc.) and more on Quantisnow.

CHIEF EXECUTIVE OFFICER Lennon David James converted options into 16,250 shares and sold $16,879 worth of shares (5,100 units at $3.31), increasing direct ownership by 33% to 44,579 units (SEC Form 4) | Quantisnow